Industry: Medical Region: Sweden Transaction Price: $1 million Transaction Method: Equity Financing
Company profile:
The company's technology comes from Uppsala University in Sweden, which is known as Cambridge in Northern Europe. Uppsala University is a university in northern Europe. It is a Swedish university with many Nobel Prize winners and fellow students of the Swedish Academy of Sciences. It has 8 serving Nobel Prize winners and 15 Nobel Prize winners among its alumni.
Research and development technology:
The company has been committed to research and development of tissue repair and anti-pathogen for many years. In recent years, it has been developing drug-free antibacterial technology and successfully developed a new generation of safe, long-acting antiviral and antibacterial technology.
Patented technology:
The company's patented technology includes a new generation of inorganic antibacterial materials and their applications. Application forms include powders, liquids, surface coatings, composites and bulk materials, which can be used on plastic products, glass, ceramics and metal surfaces. Experiments prove that it can inactivate various viruses, including human coronavirus, and its effectiveness reaches more than 99%.
The antiviral technology is funded by the Swedish High-tech Innovation Agency.
Intention to cooperate:
At present, the Company is seeking strategic partners in the Chinese market and jointly developing various product applications and market technology licenses.